News

Equinor ASA's Strategic Share Buy-back for Employee Benefits

Equinor ASA's Strategic Share Buy-back for Employee Benefits

Equinor ASA's Commitment to Employee Incentives

Equinor ASA has always placed a strong emphasis on fostering a positive work environment for its employees. A significant part of this commitment is the introduction of a buy-back program targeting shares for the benefit of its employee incentive programs.

Details of the Buy-back Program

The buy-back program was officially announced on February 7, 2024, signaling Equinor's intention to empower its workforce. Running from February 15, 2024, to January 15, 2025, the program aims to reacquire shares totaling NOK 1,774,000,000.

Objectives of the Buy-back

The primary goal of this buy-back initiative is to acquire up to 16,800,000 shares, with a phased approach where approximately 7,400,000 shares can be bought from mid-February to mid-May 2024. The remaining shares will be purchased from mid-May 2024 until January 2025. This approach is strategic to ensure a phased and effective buy-back process.

Previous Adjustments in Financial Allocations

While the previous announcement indicated a budget of NOK 1,156,000,000 for share buy-backs, Equinor has clarified that the total allocation under the current program now stands corrected at NOK 1,774,000,000, reflecting a more robust financial strategy.

Recent Transactions Overview

On November 15, 2024, Equinor successfully purchased 552,227 of its own shares at the Oslo Stock Exchange, with the shares being acquired at an average price of NOK 264.3840 each. This transaction is part of the broader plan to manage the company’s share capital effectively.

Daily Transactions Summary

This buy-back initiative has resulted in an accumulated total of 4,701,608 shares previously disclosed under this program, with an average share price of NOK 283.0944, amounting to a total transaction value of approximately NOK 1,330,998,808. To date, Equinor has carried out a total buy-back of 5,253,835 shares, maintaining an average price of NOK 281.1277, resulting in an aggregate transaction value nearing NOK 1,476,998,791.

Cumulative Impacts of Share Ownership

Following these transactions, Equinor retains ownership of a total of 53,759,167 shares, which represents about 1.92% of the company's total share capital. This ownership contributes to the strategic reduction of issued share capital, further enhancing shareholder value.

Compliance and Regulatory Information

The information regarding these buy-back transactions is made public in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act regulations, ensuring transparency in Equinor's financial practices.

Contact Information for Investor Relations

For further inquiries, the investor relations team at Equinor can provide detailed insights. Bård Glad Pedersen serves as the Senior Vice President for Investor Relations and can be reached at +47 918 01 791.

Media Relations

For media-related queries, Sissel Rinde, Vice President of Media Relations, is available for contact at +47 412 60 584.

Frequently Asked Questions

What is the purpose of Equinor ASA's buy-back program?

The buy-back program aims to acquire shares primarily for employee incentive programs, supporting their financial wellbeing and long-term commitment.

How many shares does Equinor plan to buy back?

Equinor has targeted the acquisition of up to 16,800,000 shares under this buy-back program.

When was the buy-back program announced?

The buy-back program was announced on February 7, 2024.

What is the total budget for the buy-back program?

The total budget allocated for the buy-back program is NOK 1,774,000,000.

Who can be contacted for more information?

Bård Glad Pedersen handles investor relations inquiries, and media inquiries can be directed to Sissel Rinde.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening User Protection in Cryptocurrency Trading

Updated Category News Views 189

Goldenes Intelligentes Münzhandelszentrum Enhances Trading Security Goldenes Intelligentes Münzhandelszentrum has unveiled a significant upgrade to its global user protection framework, positioning itself and its users ahead in the competitive landscape of crypto derivatives exchange. Enhanced Security Features This upgrade addresses increasing cybersecurity threats and...

Continue Reading
Upcoming Earnings: What to Expect from PPG Industries

Updated Category News Views 100

Anticipating the PPG Industries Earnings Report PPG Industries (PPG) is gearing up for its next quarterly earnings announcement, creating buzz among investors eager for insights into its financial performance. The anticipated date for this announcement is fast approaching, sparking interest and speculation. Analysts have set expectations, projecting that PPG Industries...

Continue Reading
Join the Class Action for Reckitt Benckiser Shareholders Now

Updated Category News Views 149

Understanding the Class Action for Reckitt Benckiser Shareholders Attention shareholders of Reckitt Benckiser Group plc (RBGLY). If you purchased shares during the specified class period, there is an important opportunity to join a class action. This notice is particularly pertinent for those who may have suffered losses due to the company's alleged misleading statements...

Continue Reading
Craig Gentry Strengthens Cornami's Encryption Innovations

Updated Category News Views 122

Craig Gentry Joins Cornami, Boosting Cryptographic Expertise Cornami, a company dedicated to innovative computing solutions, has appointed Dr. Craig Gentry as their Chief Scientist for Algorithms. With Dr. Gentry's impressive background in cryptography, Cornami aims to enhance its vision of providing real-time encrypted computing capabilities. About Dr. Craig Gentry: A...

Continue Reading
ICG Enterprise Trust Executes Strategic Share Buyback Initiative

Updated Category News Views 172

ICG Enterprise Trust Ongoing Commitment to Shareholder Value ICG Enterprise Trust plc has recently taken a notable step in its commitment to maximizing shareholder value. On November 19, 2024, the company initiated a buyback of 10,000 of its own shares, a strategic move aimed at optimizing its share structure. Details of the Share Buyback The shares were repurchased at an...

Continue Reading